The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...
Shares of drugmaker Catalyst Pharmaceuticals (NASDAQ: CPRX) are up a little more than 8% as of midday on Thursday, down slightly from an intraday peak gain of nearly 13%. The company's fourth-quarter ...
The FDA will issue a decision on odronextamab’s accelerated approval in relapsed/refractory follicular lymphoma by 30 July ...
The FDA canceled a critical annual flu vaccine planning meeting without explanation days after Robert F. Kennedy Jr. took ...
Some nasal wash bottles are under a voluntary recall after testing positive for a microbial contamination that could lead to ...
The Food and Drug Administration cancelled a regular meeting with the Department of Health and Human Services and other ...
The U.S. Centers for Disease Control says VRBPAC “makes the final decision about which vaccine viruses to include in the ...
The recall is classified as the second-highest risk level to consumers — meaning use of or exposure to products with the potential contamination poses a remote threat of serious adverse health ...
The rule would prevent many cereal and yogurt products from making nutrition claims and allow nuts, oils and certain seafood ...
The FDA canceled a meeting of vaccine advisors scheduled for next month to decide the composition of next season's influenza ...
A recall has been issued for SinuCleanse Nasal Wash due to Staphylococcus aureus contamination, posing serious health risks.
It is being recalled because it could be contaminated with Staphylococcus aureus, which causes staph infections.